Regeneron Pharmaceuticals (REGN)

Add to Watchlists
Create an Alert
298.96 +10.88  +3.78% NASDAQ Apr 16, 3:23PM BATS Real time Currency in USD
View Full Chart
REGN Price Chart
View All Events

REGN Events

Date Type Description
Feb 11 Misc Regeneron to Report Fourth Quarter and Full Year 2013 Financial Conference Call
Feb 11 Earnings Regeneron to Report Fourth Quarter and Full Year 2013 Financial and Operating Results. Estimate: 1.02.
Nov 05 Misc Regeneron Pharmaceuticals Q3 2013 Earnings Conference Call
Nov 05 Earnings Regeneron Pharmaceuticals Q3 2013 Earnings Results. Estimate: 0.99.
Aug 06 Misc Regeneron Pharmaceuticals Q2 2013 Earnings Conference Call
Aug 06 Earnings Regeneron to Report Second Quarter 2013 Financial and Operating Results. Estimate: 0.81.
Jun 14 Misc AGM Event for Regeneron Pharmaceuticals, Inc.
May 03 Misc Regeneron Pharmaceuticals Q1 2012 Earnings Conference Call
May 03 Earnings Regeneron to Report First Quarter 2013 Financial and Operating Results. Estimate: 0.95.
View All Performance Charts

REGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Regeneron Pharmaceuticals is up 43.01% over the last year vs S&P 500 Total Return up 22.26%, Celgene up 17.18%, and Amgen up 8.17%.

Get Quote for

Pro Report PDF for REGN

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download REGN Pro Report PDF
Advertisement

Pro Strategies Featuring REGN

Did Regeneron Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

REGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: New York
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Regeneron Pharmaceuticals, Inc., is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Recent Quotes

Symbol Price Chg Chg % Market Cap
REGN 298.96 +10.88 +3.78% 29.80B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.